$70M cash with priority voucher sale Liminal gets $70M for selling voucher at $100M (70%). They have less than a years cash and they tanked their failed top 4050 indications saying they would not put them in phase 2 in late May PR. That's why all the analysts tanked their price targets. Liminal did nothing with $500M spent for past 4 years except getting a voucher for $70M. What will they do with $70M in a year with preclinical trials? Huge markets? Tell us which? You have no clue or you would lay out the valuation potential. Nada, nothing.
So, either everything in this company was lies or Thomson is hiding potential of 4050 as Boehringher wanted to pay $900M instead of $1B in summer of 2018. Did you learn something here tonight? This is fun!